Kodiak Sciences Inc (NASDAQ: KOD)
$6.1950
+0.2950 ( +5.00% ) 134.0K
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Market Data
Open
$6.1950
Previous close
$5.9000
Volume
134.0K
Market cap
$310.48M
Day range
$5.8200 - $6.2600
52 week range
$2.1850 - $7.7700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 42 | Nov 14, 2024 |
| 8-k | 8K-related | 12 | Nov 14, 2024 |
| 8-k | 8K-related | 12 | Aug 14, 2024 |
| 10-q | Quarterly Reports | 40 | Aug 14, 2024 |
| 4 | Insider transactions | 1 | Aug 07, 2024 |
| 4 | Insider transactions | 1 | Aug 07, 2024 |
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |
| 4 | Insider transactions | 1 | Jul 01, 2024 |